This secondary analysis of the SELF trial, published in the Journal of the Academy of Nutrition and Dietetics, is the first study to use objectively date-stamped scale data (rather than self-reported recall) to track self-weighing behavior over a full 18 months, and the first to explore the mechanism behind its effect on weight loss. Fifty-five overweight or obese adults with cardiovascular risk factors were given a Carematix scale and asked to weigh in at least three times a week. The results showed that adherence to self-weighing declined steadily over time a pattern clinicians should anticipate and proactively address but during the first six months, higher adherence was strongly linked to greater weight loss, both directly and indirectly through improved adherence to calorie and exercise goals. For clinicians, this offers a clear, evidence-based rationale for prescribing regular self-weighing early in a weight-management program: it's not just a passive tracking tool, but an active driver of behavior change that reinforces dietary and activity discipline. It also flags a practical challenge since adherence naturally wanes after the first few months, clinicians may need to introduce reinforcement strategies (reminders, check-ins, or connected-device engagement features) to sustain the habit and preserve its downstream benefits on diet, exercise, and long-term weight outcomes.
Research
Association between Self-Weighing and Percent Weight Change: Mediation Effects of Adherence to Energy Intake and Expenditure Goals
Using Carematix electronic scales in an 18-month clinical trial, researchers found that consistent self-weighing directly predicted weight loss in overweight and obese adults. The study also uncovered why it works: adherence to self-weighing improved patients' ability to stick to their diet and exercise goals, which in turn drove the weight change especially during the critical first six months.
Download clinical study